<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/biomed/1471-230X-3-3.anc" start="15493" end="15497" sStart="15086" offset="407" sid="r7.1.use.v.0061" wn="1" wnkey="use%2:34:01::" annotator="veweser" text="This may reflect the fact that TNF-? therapies for IBD are aimed at efficiently clearing TNF-?, while IL-10 therapies must increase IL-10 and recombinant IL-10 is likely too rapidly cleared from the circulation after in vivo administration to provide a uniform protection [ 55 ] . On the other hand, IL-10 gene transfer technology has been used with some success in models of colitis, however its effectiveness is also variable." />
  </sentences>
</list>